Herpes simplex virus entry into cells requires the binding of envelope glycoprotein D (gD) to an entry receptor. Depending on the cell, entry occurs by different mechanisms, including fusion at the cell surface or endocytosis. Here we examined the entry mechanism through a non-HSV receptor mediated by a soluble bi-specific adapter protein composed of recognition elements for gD and the EGF receptor (EGFR). Virus entered into endosomes using either EGF or an EGFRspecific single chain antibody (scFv) for receptor recognition. Infection was less efficient with the EGF adapter which could be attributed to its weaker binding to viral gD. Infection mediated by the scFv adapter was pH sensitive, indicating that gD-EGFR bridging alone was insufficient for capsid release from endosomes. We also show that the scFv adapter enhanced infection ofEGFRexpressing tumor tissue in vivo. Our results indicate that adapters may retarget HSV infection without drastically changing the entry mechanism.
Introduction
HSV-I entry into cells is initiated by the binding of envelope glycoprotein D (gD) to one of several entry receptors, mainly nectin-l, a cell adhesion molecule, and HVEM, a member of the TNF receptor family (Campadelli-Fiume et al., 2007; Spear, 2004; Spear, Eisenberg, and Cohen, 2000) . The route ofHSV entry can vary between cells even when the same entry receptor is used, suggesting that the membrane environment and associated cell properties are key determinants of the entry pathway. Vero cells expressing endogenous nectin-I and HVEM are infected by viral envelope fusion with the plasma membrane, resulting in direct delivery of capsids into the cytoplasm (Spear, 1993) . Chinese hamster ovary (CHO) cells are resistant to HSV -1 infection due to the absence of entry receptors, but ectopic expression of nectin-I or HVEM allows infection via acidifying endosomes (Nicola, McEvoy, and Straus, 2003) . Virus internalization by B78HI mouse melanoma cells also involves endocytosis, but exposure to an acidic milieu is not required for penetration (Milne et aI., 2005) . In addition, a mechanism resembling phagocytosis has been described (Clement et aI., 2006) .
It was previously reported that replacement of the transmembrane and cytoplasmic regions of nectin-I ectopically expressed in baby hamster kidney JI.I-2 cells with the corresponding regions ofEGFR switched the HSV entry pathway from a pH-independent to a pHdependent mechanism (Gianni, Campadelli-Fiume, and Menotti, 2004) . While entry in this study involved virus binding to the nectin-I ectodomain displayed on the cell surface, we have explored the mode ofHSV entry when the virus binds to a non-HSV receptor, fulllength EGFR via a soluble bridging molecule (adapter).
We previously reported that an adapter composed of the gD-binding nectin-I variable (V) domain and a single-chain antibody (scFv) recognizing the EGFR mediated efficient infection ofEGFR-transduced CHO-KI cells that lack normal gD receptors (Nakano et aI., 2005) . Here we show that adapter-mediated EGFR-dependent infection of both Jl.I-2 and CHO-KI cells takes place by low pH-dependent endocytosis. Thus indirect gD binding to a novel receptor has the same effect on the viral entry mechanism into Jl.1-2 cells as direct gD interaction with chimeric nectin-lIEGFR. However, since HSV infection of nee tin-ltransduced CHO-KI cells occurs by low pH-dependent endocytosis, a change in entry mechanism is not obligatory for adapter-mediated infection. We also report that replacement of the scFv portion of the adapter with EGF weakened the adapter-gD interaction and reduced EGFR-dependent virus entry. Experiments to determine the effect of the scFv adapter in vivo demonstrated increased infection ofEGFR-bearing turn or tissue. Our results suggest that adapters do not fundamentally change the mechanism of HSV infection and can be utilized for enhanced gene delivery to targeted cell populations in vivo.
Materials and Methods

Cell lines
Chinese hamster ovary cells (CHO-KI, ATCC, CCL-61) were maintained in Ham's FI2K medium (Gibco-Invitrogen, Carlsbad, CA) with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 flg/ml streptomycin (Gibco-Invitrogen). CHO-gD (Kwon et aI., 2006) and CHO-EGFR (a kind gift from H. Ebina, Tokushima University, Japan) are CHO-KI derivatives constitutively expressing HSV-I gD and the human EGFR respectively. Both cell lines were grown in the above medium containing 400 flg/ml G418 (Gibco-Invitrogen). HSV-I-resistant Jl.I-2 cells (kindly provided by G. Campadelli-Fiume, Bologna, Italy) were grown in Dulbecco's MEM (Gibco-Invitrogen) containing 10% FBS, 100 U/ml penicillin and 100 flg/ml streptomycin. J-EGFR cells were generated by transfection of JI.I-2 cells with a human EGFR expression plasmid (EGFRlpCx5 ori, a gift from I. Pastan, NTH, Bethesda, MD) and cloning of G418-resistant cells. Human lung cancer A549, glioblastoma U-87MG, and breast cancer MCF-7 cells were purchased from ATCC (Manassas, V A).
Virus
QOZHG is a replication-defective derivative ofHSV-1 strain KOS (Chen et aI., 2000) .
Briefly, QOZHG is deleted for the immediate early (IE or a) genes ICP4 and ICP27 and expresses the ICP22 and ICP47 lE genes from early (E or ~) promoters. The virus contains an expression cassette for bacterial ~-galactosidase in the UL 41 locus and for enhanced green fluorescent protein (eGFP) in U L S4 (ICP27). QOZHG was grown and titered on ICP4/ ICP27-complementing 7b cells (Krisky et aI., 1997) .
Adapter proteins
1) Plasmid constructs-The bacterial expression construct pRA-V-S28LH for production of the scFv adapter was previously described (Nakano et aI., 2005) . An expression construct for the EGF adapter, termed pRA-V-EGF, was derived from pRA-V-S28LH by replacing the XhoI-SacII fragment spanning the scFv region with the complete EGF open reading frame (Fig. lA) . The EGF fragment was obtained by PCR using a human EGF cDNA plasmid (kindly provided by I. Dmitriev, University of Alabama) as template and a pair of primers that added a XhoI site immediately upstream of the open reading frame and a SacII site immediately downstream. The primer sequences were as follows: forward, 5'-GGGGCT CGAGAATAGTGACTCTGAATGTCCCCTGTCC-3'; reverse, 5'-CTGCAGCCGCGGAG CGCAGTTCCCACCACTTCAGGTCTCG-3'.
2) Production of adapter proteins-Adapter proteins were produced as previously described (Nakano et aI., 2005) . Briefly, E. coli BL21 (DE3) cells were transformed with pRA-V-EGF or pRA-V-S28LH and grown at 28 C C in 2xYT broth supplemented with 100 flglmL ampicillin. Expression of recombinant proteins (EGF -or scFv-adapter, respectively) was induced by addition of I mM isopropyl-I-thio-~-D-galactopyranoside (IPTG). After overnight culture, bacterial pellets were collected by centrifugation (2,000 x g, 35 min) and solubilized with 10 ml of 6 M guanidinium hydrochloride (Sigma-Aldrich, SI. Louis, MO) in PBS (Gu-HCVPBS) overnight at 4 C C, Protein samples were purified on a 2 ml TALON metal affinity column (Clontech, Palo Alto, CA) by elution with Gu-HC1IPBS containing 2S0mM imidazole. The recovered protein was refolded by sequential dialysis against Gu-HC1IPBS and PBS (pH 7.9), centrifuged at 4,500 x g for 20 min at 4 c C, and sterilized by filtration through a 0.22 flill ultrafiltration membrane (Millipore, Tokyo, Japan).
HSV-1 entry assays
Cells were grown to confluence in 96-well plates (5 x 104 cells/well) in medium containing 10% FBS. QOZHG virus and adapters were inoculated with the cells in 40 flL of serum-free medium for 2 h at 37 C C, The cells were washed once with PBS, overlaid with fresh 10% FBS medium, and incubated for 16 h at 37 c C, Entry was evaluated as previously described (Nakano et aI., 2005) , including: (i) visual inspection of monolayers for GFP reporter gene expression under a fluorescent microscope; (ii) staining of fixed cultures with ~ galactosidase colorimetric substrate, S-bromo-4-chloro-3-indolyl-~-D-galactopyranoside (Xgal, 0.2 mg/ml; Sigma-Aldrich); or (iii) ONPG assay to determine ~-galactosidase levels in triplicate-infected cultures. ONPG assays involved cell lysis in ISO)1l of 1% NP-40, I mM MgCI 2 , 50 mM ~-mercaptoethanol and 4 mg/ml ~-galactosidase substrate o-nitrophenyl-~ D-galactopyranoside (ONPG; Sigma-Aldrich), incubation at 37 cC for 15-20 min until a faint yellow color developed, and measurement of absorbance at 405 nm.
Effect of blocking agents on adapter-mediated infection
Stock solutions of ammonium chloride, bafilomycin AI, amiloride, cytochalasin D, dansylcadaverine (all from Sigma-Aldrich), sucrose, and filipin (WAKO, Osaka, Japan) were prepared in de-ionized water or ethanol and adjusted to pH 7.4 just before use. Cells were pre-incubated in FI2K or DMEM media in triplicate with different concentrations of the drugs or sucrose for 30 min, infected with QOZHG (MOI~3) and scFv adapter for 2 h in the continued presence of the inhibitor, cultured in fresh media for 16 h, and examined for HSV entry by ONPG assay.
Transmission electron microscopy
QOZHG (M0I~1O) and adapters (30 flg/mL) were adsorbed to cells at 4 C C for I h and entry was initiated by raising the temperature to 37 C C for 0-30 min, as above. The cells were then washed with cold phosphate buffer (pH 7.2) and fixed with 2.5% glutaraldehydeil % osmium tetraoxide. Samples were embedded in epoxy resin (Oken, Japan) and ultra thin sections (70 mn) were double stained with uranyl acetate and lead citrate for observation under a transmission electron microscope (H-7000, Hitachi, Japan) (Ishikawa et aI., 2006) .
Flow cytometry
To compare the affinities of the scFv and EGF adapters for EGFR or HSV-gD, the adapters (30 flglmL in FI2KIHEPES buffer) were adsorbed to cells expressing EGFR or gD (2 x 105 cells/24-well plate) at 4 C C for I h. The cells were washed, re-suspended in PBS, and incubated with anti-c-Myc antibody at 4 C C for I h and secondary PE-conjugated anti-mouse IgG for 30 min. After washing with BD FACSFlow solution (BD Biosciences Pharmingen), adapter binding to the cells was evaluated by BD FACSCalibur flow cytometry. 
Tumor infection in vivo
Results
EGFR-overexpressing
Adapter construction
Unlike EGF, the scFv used in our previous EGFR targeting adapter is not a signaling ligand (Gill et aI., 1984) , and thus it was of interest to determine whether replacement of the scFv with EGF would provide an effective adapter. As illustrated in Fig. lA , the two adapters contained the same gD-binding variable domain of human nectin-I (V-nee) followed by a spacer (SI) at the amino terminus and the same epitope tags at the carboxyl terminus, but differed in the EGFR-interacting sequences linking these elements. Both adapters were produced by bacterial expression as previously described (Nakano et aI., 2005) . Fig. lE shows a Coomassie-stained gel of samples of the purification steps. Both purified adapters were readily detected by immunoblotting using an antibody directed against the c-Myc tag (data not shown).
HSV entry-mediating activities
The abilities of the two adapters to mediate HSV entry into CHO-EGFR and J-EGFR cells, which lack receptors for gD but stably express human EGFR were examined by reportergene assays using a replication-defective, dual reporter gene (lacZ and eGFP) recombinant virus, QOZHG (Chen et aI., 2000) . Based on our previous determination that 30 flg/ml of scFv adapter is saturating for QOZHG entry into CHO-EGFR cells at an MOl of 3 (Nakano et aI., 2005) , we used these conditions to compare the entry-mediating activities of the two adapters. Visualization of ~-galactosidase (LacZ) activity at 16 h post-infection (p.i.)
showed that both adapters mediated EGFR-dependent infection of CHO cells ( Fig. 2A) and J cells (Fig. 2B) . Quantitative measurement ofLacZ activity by ONPG assay (see Materials and Methods) demonstrated that virus entry was MOl-dependent and that the scFv adapter was approximately IS-fold more effective than the EGF adapter at MOls where EGF adapter-mediated entry above background was detectable (Fig. 2C, D) .
Comparative adapter binding to the EGFR and HSV gO
To identify differences between the two adapters that could be responsible for the difference in their entry-mediating efficiencies, we examined the binding of the adapters to the EGFR and HSV-I gD expressed on separate CHO cell lines (CHO-EGFR and CHO-gD, respectively). The cells were incubated for 90 min at 4 C C with the same adapter concentrations as used in the entry assays and immunofluorescent staining was perfonned with an antibody directed against the c-Myc tag. Flow cytometry demonstrated similar binding of the two adapters to CHO-EGFR cells (Fig. 3A) , but greater binding of the scFv adapter than the EGF adapter to CHO-gD cells (Fig. 3B) . While surprising since both adapters had the same gD recognition domain, this result indicated that the affinity of the scFv adapter for gD was higher than that of the EGF adapter, possibly due to differential effects of the EGFR-recognition component of the adapters on the refolding efficiency of the bacterially produced proteins or the refolded conformation of the nectin portion. Given this binding difference, we abandoned the EGF adapter for the remainder of this study except where used as a negative control.
Mechanism of adapter-mediated virus entry
To determine the pathway of scFv adapter-mediated entry, we first tested the sensitivity of virus infection to lysosornotropic agents that block endosome acidification. On pre-treatment of CHO-EGFR or J-EGFR cells with ammonium chloride or bafilomycin Al (BFLA), dosedependent inhibition of adapter-mediated QOZHG infection was observed (Fig. 4A) . We used a relatively low MOl to avoid potential artifacts due to overloading of the cells and removed the drugs at 2 h post-infection to avoid drug-associated toxicity. These conditions precluded definitive determination whether all infection involved virus passage through acidified endosomes or whether some degree of entry (20-25% based on the BFLA results) might take place by a pH-independent pathway.
We next examined whether scFv adapter-mediated virus entry involved clathrin-coated pits, caveolae, or rnacropinocytosis. Dose-dependent decreases in infection were observed on J-EGFR and, less pronounced, CHO-EGFR cells treated with sucrose or dansylcadaverine (inhibitors of clathrin-dependent uptake) or with amiloride or cytochalasin D (inhibitors of micropinocytosis) (Mercer and Helenius, 2009) , whereas filipin had a small, doseindependent effect (Fig. 4B) . These results suggested that scFv adapter-mediated virus entry into both cell lines occurred at least in part by clathrin-dependent endocytosis, the dominant mechanism of ligand-induced EGFR internalization, and macropinocytosis, a clathrinindependent mechanism observed at high EGF and/or EGFR levels (Sorkin and Goh, 2008) . The consistently smaller effects of the different inhibitors on CHO-EGFR than on J-EGFR cells may be due to differences between the two lines in their uptake or intracellular clearance of the inhibitory agents. We did not test corn binations of the different drugs due to increased toxicity at the effective concentrations of the individual drugs. Moreover, we note that Mercer and Helenius (2009) list additional criteria for macropinocytosis that have not been examined here.
Transmission electron microscopy was perfonned on cells incubated for 15 or 30 min at 37°C following virus adsorption. At 15 min, we saw virions in cytoplasmic vesicles of CHO-EGFR cells in the presence of the scFv adapter, some intimately associated with the vesicle membrane (Fig. 5A, large arrows) , but obtained no evidence of fusion at the cell surface. In addition, capsids could be distinguished in the perinuclear area (Fig. 5A, B, small  arrows) . At 30 min, more capsids were observed near the nucleus along with an occasional large cytoplasmic vesicle containing defonned virions not clearly associated with the vesicle membrane (Fig. 5e) . Particles in the process of fusing with the vesicle membrane were seen at 30 min in J-EGFR cells (Fig. 5D ), but no clear examples were captured in CHO-EGFR cells, perhaps indicating that this is a rapid event in CHO-EGFR cells. These findings were consistent with endocytic HSV uptake by both cell lines in the presence of the scFv adapter and subsequent capsid release into the cytoplasm. The presence of degrading virions in large vesicles at 30 min in CHO-EGFR cells may suggest that some virus particles may have been insufficiently complexed with the adapter to escape from endosomes, similar to the reported fate ofHSV incubated with receptor-deficient CHO cells (Nicola, McEvoy, and Straus, 2003) . In addition, it is possible that some of these particles represented endocytosed defective virions present in the vector stock. As expected, infection in the presence of the EGF adapter showed no evidence of cytoplasmic capsids or membrane fusion in CHO-EGFR and J-EGFR cells at 15 min (data not shown) or 30 min (Fig. 5E, F) . Intact and degrading virus particles were observed in vesicles, consistent with endosornal uptake without subsequent fusion-mediated release. Together, these observations indicated that the scFv adapter enabled envelope fusion with the endosomal membrane in both CHO-EGFR and J-EGFR cells to deliver capsids into the cytoplasm, whereas the EGF adapter lacked this ability most likely as a result of its reduced association with virion gD.
Adapter-mediated infection in vivo
Since adapters are readily re-engineered, they may provide a flexible method to introduce replication-defective HSV gene transfer vectors into specific cell populations in vivo as a means to study these cells in their natural environment. We assessed the feasibility of this approach using a turn or model since turnors represent a relatively homogeneous population of target cells. In vitro infection assays showed that the scFv adapter augmented QOZHG infection ofEGFR-overexpresssing U-87MG glioblastoma cells, but not of control MCF-7 breast cancer cells that express low levels of the receptor (Reilly and Gariepy, 1998) (Fig.  6A, B) , indicating that the scFv adapter can increase infection of cells that express both HSV receptors andEGFR We then usedEGFR-overexpressing, HSV-susceptible A549 cells to fonn subcutaneous turnors and assessed infection 2 days after intraturnoral injection of QOZHG with or without adapter. The results demonstrated widespread GFP fluorescence in the presence of the adapter compared to limited fluorescence in its absence (Fig. 6C) , suggesting that the scFv adapter can be used to enhance HSV-mediated gene delivery to targeted cell populations even if the target cells express authentic HSV entry receptors. While our data do not show infection exclusively through the targeted receptor, they suggest that this may be achievable with suitable modifications to the vector and/or adapter, as recently discussed (Baek et aI., 2010) .
Discussion
HSV infection has long been considered to occur exclusively via pH-independent viral envelope fusion with the plasma membrane (Spear, 1993) . However, several reports in the past few years have demonstrated that the virus can use other mechanisms to gain entry into cells. Nicola and co-workers first presented evidence of pH-dependent endocytic HSV entry into HeLa cells and CHO cells modified to express human nectin-l or HVEM (Nicola, McEvoy, and Straus, 2003) . Subsequently, pH-independent endocytic infection was described for murine melanoma cells expressing human nectin-l (Milne et aI., 2005) . It has been suggested that endocytic virus uptake by keratinocytes, HeLa and CHO cells involves macropinocytosis (Mercer and Helenius, 2009; Nicola et aI., 2005) , while evidence of a phagocytosis-like mechanism has been reported for both CHO-nectin-l and corneal fibroblast cells (Clement et aL, 2006) . In all of these instances, interaction ofHSV gD with an entry receptor is essential for membrane fusion resulting in viral capsid delivery to the cytoplasm.
Taking advantage of this understanding of the central role of gD and its receptors in HSV entry, several strategies have been pursued to enable HSV infection via alternate receptors. One strategy involves virus engineering to abolish gD recognition of its natural receptors (detargeting) and incorporate a new ligand into gD for interaction with the new target receptor (retargeting) (Menotti et aL, 2009; Zhou and Roizman, 2006) . A second strategy does not require virus re-engineering but instead employs bi-specific adapters that can function as an attachment bridge for the virus to the target receptor; without modifications (van Beusechem et aL, 2003; Verheije et aL, 2006) , this method is restricted to a single round of virus entry and is therefore primarily useful for targeted transgene delivery by replication-defective vectors.
We previously demonstrated that an EGFR-specific adapter employing the gD-binding V domain of nectin-l and an anti-EGFR scFv was effective in mediating virus infection through the EGFR (Nakano et aL, 2005) . In the present study, we explored the cellular pathway utilized by the virus for entry via this adapter and determined whether an alternate adapter designed to target the same receptor through a natural ligand could be effective as welL Although EGFR recognition was similar between the scFv and EGF adapters, we found that the EGF adapter was much less effective in mediating virus infection, likely because of its weak binding to viral gD limiting stable virus-adapter complex formation; without stably bound adapter, internalized virions were expected to remain trapped in endosomes as previously reported (Nicola and Straus, 2004) and observed here. In contrast, we propose that stable association of the scFv adapter with the targeted receptor and viral gD resulted in endocytic co-internalization of the complex allowing membrane fusion in acidifying endosomes and capsid release into the cytoplasm. This suggestion is based on the evidence that scFv adapter-mediated entry involves low pH-dependent endocytosis along with our previous observation that the process requires binding of the adapter to both the targeted receptor and viral gD (Nakano et aL, 2005) .
We previously reported that the V domain of nectin-l can mediate efficient HSV entry as a soluble molecule not anchored in or attached to the cell membrane (Kwon et aI., 2006) . In addition, we showed that virion attachment to cell-surface proteoglycans is essential in this instance. Our experiments in the present study allowed for virus attachment to proteoglycans, raising the question why adapter-mediated infection required a gD receptoL It is possible that the conformation of the nectin-l portion of the receptor is altered by its fusion to the scFv region, precluding gD activation without additional changes induced by EGFR binding and an acidic enviromnent. The reduced gD binding activity of the EGF adapter is consistent with the suggestion that the confonnation of the nectin-l V domain is sensitive to C-terminal additions, as also suggested by our previous finding that the soluble V domain blocks HSV infection of nectin-l expressing cells while the scFv adapter does not (Nakano et aL, 2005) .
The evidence presented in this study that the scFv adapter was able to increase the area of infection in the relatively homogeneous target cell population provided by a tumor supports the feasibility of using adapters for HSV-mediated gene transfer to specific populations of cells in vivo, such as neuronal subtypes in the brain that can be differentially targeted based on their unique receptor profiles (Anliker et aI., 2010) . This would involve the use of replication-defective vectors like QOZHG that enter a latent-like state upon infection, leaving cellular gene expression essentially unaltered while allowing short-or long-term transgene expression from different promoters (Craft et aI., 2008; Krisky et aI., 1998; Puskovic et aI., 2004; Wu et aI., 1996) . Such a system could be used to label specific cell populations with reporter genes and/or to examine the effect of adding or blocking certain gene functions exclusively in these cells. Our current adapters rely on the ability of gD to bind to either nectin-1 (Nakano et aI., 2005) or HVEM (Baek et aI., 2010) and can be used in combination with our recently described nectin-l-or HVEM-restricted mutant vectors (Uchida et aI., 2009) to reduce infection through the natural HSV receptors present on a broad range of cells. Ultimately, adapter-vector pairs can be designed that no longer require gD binding to one of its cognate receptors and such corn binations will allow virus entry exclusively via the targeted receptoL Adapters provide greater flexibility than currently described retargeted HSV vectors since adapter specificity can be readily changed by incorporation of a different scFv (Baek et aI., 2010) while the ground rules for efficient HSV retargeting via ligand or scFv incorporation into gD remain to be finnly established. Adapters may therefore be a practical and broadly applicable tool to study and modify the function of specific cells in mixed cell populations. Tumors were grown to ~8 mm in diameter and injected with 1 x 10 7 pfu of QOZHG virus in the presence or absence of 25 !1g scFv adapter. Two days later, tumors were surgically removed and processed for GFP detection and DAPI nuclear staining. Each section is from a different animal treated with virus plus adapter (panels 1,2) or virus alone (panels 3, 4). Scale bars: 100 !!ill.
